Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
The International Journal of Biological Markers|November 8, 2024
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trialStefano Indraccolo, Simona Signoriello, Ilaria Piga, et al.
The Oncologist|May 31, 2022
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER StudyMartina Lorenzi, Alessandra Ferro, Fabiana Cecere, et al.
Theranostics|January 7, 2021
Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemiaHuizhong Xiong, Maicol Mancini, Michael Gobert, et al.
Neuro-Oncology|July 15, 2020
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenibAlessandra Santangelo, Marzia Rossato, Giuseppe Lombardi, et al.
NPJ Precision Oncology|November 17, 2025
Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trialEliana Pivetta, Vincenzo Canzonieri, Marina Bagnoli, et al.
Oncogene|June 21, 2024
Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALLIlaria Sergio, Claudia Varricchio, Sandesh Kumar Patel, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Oncotarget|September 23, 2016
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACCFrancesco Perrone, Gustavo Baldassarre, Stefano Indraccolo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2025
A decalogue of Molecular Tumor Board (MTB) recommendations from the CAN.HEAL ConsortiumGennaro Ciliberto, Ruggero De Maria, Patrizio Giacomini, et al.
Cancer Letters|February 29, 2024
Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective studyEvelina Miele, Elena Anghileri, Chiara Calatozzolo, et al.
Pageof 16